Advertisement

Topics

AmerisourceBergen Urges Policymakers to Support Regulator and Industry Data Transparency to More Effectively Combat Opioid Abuse

09:00 EST 13 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
The Company aims to advance policies to better enable DEA, distributors, and pharmacies to more effectively collaborate to identify and stop nefarious supply chain actors AmerisourceBergen, a global healthcare solutions lead...

Other Sources for this Article

AmerisourceBergen Corporation
Media
Gabe Weissman
Group Vice President, Communications
610-727-3696 – Office
267-438-7998 – Mobile
gweissman@amerisourcebergen.com

NEXT ARTICLE

More From BioPortfolio on "AmerisourceBergen Urges Policymakers to Support Regulator and Industry Data Transparency to More Effectively Combat Opioid Abuse"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...